成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Ganirelix Acetate

Ganirelix Acetate Struktur
123246-29-7
CAS-Nr.
123246-29-7
Englisch Name:
Ganirelix Acetate
Synonyma:
GANIRELIX;Ganirelixum;5-?dihydroxy-;3-?bis[[3-?(3;ganirelix Acetate;Ganirelix DiAcetate;Ganirelix Impurity 1;Ganirelix Acetate API;Ganirelix Acetate USP/EP/BP;4-?dihydroxyphenyl)?-?1-?oxo-?2-?propen-?1-?yl]?oxy]?-?4
CBNumber:
CB61370494
Summenformel:
C80H113ClN18O13
Molgewicht:
1570.34
MOL-Datei:
123246-29-7.mol

Ganirelix Acetate Eigenschaften

Sequenz
Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-Tyr-D-Har(Et2)-Leu-Har(Et2)-Pro-DAla-NH2

Sicherheit

HS Code  3504009000

Ganirelix Acetate Chemische Eigenschaften,Einsatz,Produktion Methoden

Originator

Antagon,Organon

Therapeutic Function

LHRH antagonist

Clinical Use

Ganirelix acetate is an analog of GnRH with substitutions at residues 1, 2, 3, 6, 8, and 10. It is not a superagonist but, rather, is a synthetic decapeptide with high antagonist activity and the first GnRH antagonist to be marketed. It is approved for the suppression of LH surges in women who are undergoing ovarian hyperstimulation fertility treatment; LH surges normally promote ovulation. The goal of this drug is to significantly reduce the number of medication days necessary to suppress the LH surge, thereby maintaining eggs in the ovaries. In vitro fertilization (IVF) treatment cycles were historically initiated by the administration of leuprolide acetate to suppress the premature release of LH. This inhibits ovulation so that the eggs remain available for retrieval by a fertility specialist. For this purpose, leuprolide acetate usually is injected for as many as 26 days. Clinical studies have shown that ganirelix acetate can shut down the LH surge in only 5 days of treatment, that the suppression of LH is more pronounced than that of FSH, and that the shorter treatment time minimizes unpleasant side effects, such as hot flashes and headaches.

Ganirelix Acetate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Ganirelix Acetate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 178)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hebei Chuanghai Biotechnology Co,.LTD
+86-13131129325
sales1@chuanghaibio.com China 5857 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8615965530500
nickzhang@hangyubiotech.com China 10983 58
Shanghai Affida new material science and technology center
+undefined15081010295
admin@oudaxin.com China 114 58
hebei hongtan Biotechnology Co., Ltd
+852-6619 3215 +86-17731935328
sales03@chemcn.cn China 970 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+86-17396673057
linda@tnjone.com China 1143 58
Adachibio Inc.
+81-8027837258
sales@adachi-bio.com Japan 992 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21628 55
Shenzhen Nexconn Pharmatechs Ltd
+86-755-89396905 +86-15013857715
admin@nexconn.com China 10406 58
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19552 58
Shanghai Longyu Biotechnology Co., Ltd.
+8619521488211
info@longyupharma.com China 2556 58

123246-29-7()Verwandte Suche:


  • Ac-DNal-DCpa-DPal-Ser-Tyr-DHar(Et2)-Leu-Har(Et2)-Pro-DAla -NH2
  • ganirelix Acetate
  • GANIRELIX
  • Ganirelixum
  • Ganirelix Acetate USP/EP/BP
  • Ganirelix Impurity 1
  • Ganirelix Acetate API
  • 3-?bis[[3-?(3
  • 4-?dihydroxyphenyl)?-?1-?oxo-?2-?propen-?1-?yl]?oxy]?-?4
  • 5-?dihydroxy-
  • Ganirelix DiAcetate
  • 123246-29-7
  • 23246-29-7
  • C80H113ClN18O13
  • hormones
Copyright 2019 ? ChemicalBook. All rights reserved